Integrins as Therapeutic Targets for SARS-CoV-2

被引：7
|
作者：
Gressett, Timothy E. [1 ,2 ,3 ]
Nader, Danielle [4 ]
Robles, Juan Pablo [5 ]
Buranda, Tione [6 ]
Kerrigan, Steven W. [4 ]
Bix, Gregory [1 ,2 ,3 ]
机构：
[1] Tulane Univ, Clin Neurosci Res Ctr CNRC, Sch Med, New Orleans, LA USA
[2] Tulane Univ, Dept Neurol, Sch Med, New Orleans, LA USA
[3] Tulane Univ, Tulane Brain Inst, New Orleans, LA USA
[4] RCSI Univ Med & Hlth Sci, Sch Pharm & Biomol Sci PBS, Dublin, Ireland
[5] Univ Nacl Autonoma Mexico, Inst Neurobiol, Juriquilla, Mexico
[6] Univ New Mexico Hlth Sci Ctr HSC, Dept Pathol, Albuquerque, NM USA
来源：
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2022年 / 12卷
关键词：
integrins; SARS-CoV-2; therapeutic; RGD; ATN-161; cilengitide; PEPTIDE; ATN-161;
D O I：
10.3389/fcimb.2022.892323
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
    Trigueiro-Louro, Joao
    Correia, Vanessa
    Figueiredo-Nunes, Ines
    Giria, Marta
    Rebelo-de-Andrade, Helena
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2020, 18 : 2117 - 2131
  • [32] Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?
    Onay, Ahmet
    Ertas, Abdulselam
    Suzerer, Veysel
    Yener, Ismail
    Yilmaz, Mustafa Abdullah
    Ayaz-Tilkat, Emine
    Ekinci, Remzi
    Bozhan, Nesrin
    Irtegun-Kandemir, Sevgi
    TURKISH JOURNAL OF BIOLOGY, 2021, 45 (04) : 570 - 587
  • [33] Engineered Therapeutic Antibody Against SARS-CoV-2
    Monrat Chulanetra
    Current Clinical Microbiology Reports, 2023, 10 : 222 - 235
  • [34] An intranasal ASO therapeutic targeting SARS-CoV-2
    Zhu, Chi
    Lee, Justin Y.
    Woo, Jia Z.
    Xu, Lei
    Nguyenla, Xammy
    Yamashiro, Livia H.
    Ji, Fei
    Biering, Scott B.
    Van Dis, Erik
    Gonzalez, Federico
    Fox, Douglas
    Wehri, Eddie
    Rustagi, Arjun
    Pinsky, Benjamin A.
    Schaletzky, Julia
    Blish, Catherine A.
    Chiu, Charles
    Harris, Eva
    Sadreyev, Ruslan I.
    Stanley, Sarah
    Kauppinen, Sakari
    Rouskin, Silvi
    Naar, Anders M.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [35] An intranasal ASO therapeutic targeting SARS-CoV-2
    Chi Zhu
    Justin Y. Lee
    Jia Z. Woo
    Lei Xu
    Xammy Nguyenla
    Livia H. Yamashiro
    Fei Ji
    Scott B. Biering
    Erik Van Dis
    Federico Gonzalez
    Douglas Fox
    Eddie Wehri
    Arjun Rustagi
    Benjamin A. Pinsky
    Julia Schaletzky
    Catherine A. Blish
    Charles Chiu
    Eva Harris
    Ruslan I. Sadreyev
    Sarah Stanley
    Sakari Kauppinen
    Silvi Rouskin
    Anders M. Näär
    Nature Communications, 13
  • [36] Therapeutic antibodies under development for SARS-CoV-2
    Ma, Zetong
    Zhu, MengMei
    Zhang, Shuyi
    Qian, Kewen
    Wang, Chuqi
    Fu, Wenyan
    Lei, Changhai
    Hu, Shi
    VIEW, 2022, 3 (02)
  • [37] Engineered Therapeutic Antibody Against SARS-CoV-2
    Chulanetra, Monrat
    CURRENT CLINICAL MICROBIOLOGY REPORTS, 2023, 10 (04) : 222 - 235
  • [38] SARS-CoV-2 and UPS with potentials for therapeutic interventions
    Ferdoush, Jannatul
    Kadir, Rizwaan Abdul
    Kaplanoglu, Selin Simay
    Osborn, Morgan
    GENE, 2024, 912
  • [39] Potential Therapeutic Target and Vaccines for SARS-CoV-2
    Hussain, Mohamed A.
    Hassan, Mohamed M.
    Bashir, Bashir Abdrhman
    Gamar, Tarig A.
    Gasmalbari, Elmuaiz
    Mohamed, Ahmed Osman
    Osman, Wadah
    Sherif, Asmaa E.
    Elgaml, Abdelaziz
    Alhaddad, Aisha A.
    Ghazawi, Kholoud F.
    Miski, Samar F.
    Ainousah, Bayan E.
    Andijani, Yusra Saleh
    Ibrahim, Sabrin R. M.
    Mohamed, Gamal A.
    Ashour, Ahmed
    PATHOGENS, 2023, 12 (07):
  • [40] Lymphocyte integrins mediate entry and dysregulation of T cells by SARS-CoV-2
    Mengwen Huang
    Xingchao Pan
    Xinling Wang
    Qingfei Ren
    Bei Tong
    Xianchi Dong
    Gaoxiang Ge
    Lu Lu
    Shibo Jiang
    Jianfeng Chen
    Signal Transduction and Targeted Therapy, 8
12345